122 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Kris
    Kris
  4. Miller
    Miller
  5. Norton
    Norton
  6. Dickler
    Dickler
  7. Ginsberg
    Ginsberg
  8. Krug
    Krug
  9. Schwartz
    Schwartz
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (74)
  3. Genitourinary Oncology Service (27)
  4. Survivorship Research (23)
  5. Hematologic Malignancies, Division of (18)
  6. Radiology, Department of (16)
  7. Breast Medicine Service (15)
  8. Center for Hematologic Malignancies (15)
  9. Body Imaging Service (14)
  10. Gastrointestinal Oncology Service (13)
  1. "epistaxis"
Formats
  1. Journal Article (115)
  2. Review (3)
  3. Research Letter (2)
  4. Conference Paper (1)
  5. Correspondence (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (74)
  3. Genitourinary Oncology Service (27)
  4. Survivorship Research (23)
  5. Hematologic Malignancies, Division of (18)
  6. Radiology, Department of (16)

More Groups

People
  1. Robert Motzer (23)
  2. Vincent Miller (9)
  3. Clifford Hudis (8)
  4. Mark Kris (8)
  5. Larry Norton (6)
  6. Lawrence Schwartz (5)

More People

Years
  1. 2025 (5)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Clinical Cancer Research (8)
  3. Cancer (5)
  4. Lancet Oncology (5)
  5. New England Journal of Medicine (5)
  6. Clinical Breast Cancer (4)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. American Society of Clinical Oncology (12)
  3. Wiley Blackwell (10)
  4. American Association for Cancer Research (9)
  5. Elsevier Science, Inc. (8)
  6. Nature Publishing Group (8)

More Publishers

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
    Journal Article

    Nooka, A. K.; Cohen, A. D.; Lee, H. C.; Badros, A.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; Libby, E. N.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Journal Article

    Raj, N.; Chan, J. A.; Wang, S. J.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Fong, L.; Grabowsky, J.; Hope, T. A.; Kolli, K. P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
    Journal Article

    Issa, G. C.; Aldoss, I.; DiPersio, J.; Cuglievan, B.; Stone, R.; Arellano, M.; Thirman, M. J.; Patel, M. R.; Dickens, D. S.; Shenoy, S.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Szczylik, C.; Pili, R.; Bjarnason, G. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
    Journal Article

    Yoshino, T.; Andre, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Ibrutinib treatment of pediatric chronic graft-versus-host disease: Primary results from the phase 1/2 iMAGINE study
    Journal Article

    Carpenter, P. A.; Kang, H. J.; Yoo, K. H.; Zecca, M.; Cho, B.; Lucchini, G.; Nemecek, E. R.; Schultz, K. R.; Stepensky, P.; Chaudhury, S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors
    Journal Article

    Calvo, E.; Sessa, C.; Harada, G.; de Miguel, M.; Kahatt, C.; Luepke-Estefan, X. E.; Siguero, M.; Fernandez-Teruel, C.; Cullell-Young, M.; Stathis, A.; more...
    Investigational New Drugs (2022)

    Fulltext@MSK | Save
  • Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
    Journal Article

    Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save